Interleukin-18 promoter genotype is associated with the risk of nasopharyngeal carcinoma in Taiwan

References

• LinCLLoWFLeeTHImmunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinomaCancer Res200262236952695812460912
   PubMed Web of Science ®Google Scholar
• O’NeilJDOwenTJWoodVHEpstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitroJ Gen Virol200889Pt 112833284218931081
   PubMed Web of Science ®Google Scholar
• ChengYJHildesheimAHsuMMCigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in TaiwanCancer Causes Control199910320120710454065
   PubMed Web of Science ®Google Scholar
• LongMFuZLiPNieZCigarette smoking and the risk of nasopharyngeal carcinoma: a meta-analysis of epidemiological studiesBMJ Open2017710e016582
   PubMed Web of Science ®Google Scholar
• ChangWSWangSCChuangCLContribution of interleukin-4 genotypes to lung cancer risk in TaiwanAnticancer Res201535116297630126504066
   PubMed Web of Science ®Google Scholar
• LoWJChangWSHsuHFSignificant association of interleukin-10 polymorphisms with childhood leukemia susceptibility in TaiwanIn Vivo201630326526927107085
   PubMed Web of Science ®Google Scholar
• ChangWSLiaoCHTsaiCWThe role of IL-10 promoter polymorphisms in renal cell carcinomaAnticancer Res20163652205220927127124
   PubMed Web of Science ®Google Scholar
• ShenTCTsaiCWChangWSAssociation of Interleukin-12A rs568408 with Susceptibility to Asthma in TaiwanSci Rep201771319928600552
   PubMedGoogle Scholar
• FarjadfarAMojtahediZGhayumiMAInterleukin-18 promoter polymorphism is associated with lung cancer: a case-control studyActa Oncol200948797197619642044
   PubMed Web of Science ®Google Scholar
• NakanishiKYoshimotoTTsutsuiHOkamuraHInterleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieuCytokine Growth Factor Rev2001121537211312119
   PubMed Web of Science ®Google Scholar
• GołabJInterleukin 18--interferon gamma inducing factor--a novel player in tumour immunotherapy?Cytokine200012433233810805213
   PubMed Web of Science ®Google Scholar
• OkanoFYamadaKCanine interleukin-18 induces apoptosis and enhances Fas ligand mRNA expression in a canine carcinoma cell lineAnticancer Res2000205B3411341511131641
   PubMed Web of Science ®Google Scholar
• ParkCCMorelJCAminMAEvidence of IL-18 as a novel angiogenic mediatorJ Immunol200116731644165311466388
   PubMed Web of Science ®Google Scholar
• Vidal-VanaclochaFMendozaLTelleriaNClinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progressionCancer Metastasis Rev200625341743417001512
   PubMed Web of Science ®Google Scholar
• GünelNCoşkunUSancakBGünelUHasdemirOBozkurtSClinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patientsCancer200295366366712209760
   PubMed Web of Science ®Google Scholar
• GiedraitisVHeBHuangWXHillertJCloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulationJ Neuroimmunol20011121–214615211108943
   PubMed Web of Science ®Google Scholar
• WeiYSLanYLiuYGInterleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinomaActa Oncol20074681090109617851835
   PubMed Web of Science ®Google Scholar
• LiuYLinNHuangLXuQPangGGenetic polymorphisms of the interleukin-18 gene and risk of prostate cancerDNA Cell Biol200726861361817688413
   PubMed Web of Science ®Google Scholar
• NikiteasNYannopoulosAChatzitheofylaktouATsigrisCHeterozygosity for interleukin-18 -607 A/C polymorphism is associated with risk for colorectal cancerAnticancer Res2007276B3849385318225542
   PubMed Web of Science ®Google Scholar
• BushleyAWFerrellRMcduffieKPolymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancerGynecol Oncol200495367267915581980
   PubMed Web of Science ®Google Scholar
• Khalili-AzadTRazmkhahMGhiamAFAssociation of interleukin-18 gene promoter polymorphisms with breast cancerNeoplasma2009561222519152241
   PubMed Web of Science ®Google Scholar
• VairaktarisESerefoglouZCYapijakisCThe interleukin-18 -607A/C polymorphism is not associated with risk for oral cancerAnticancer Res2007276B4011401418225563
   PubMed Web of Science ®Google Scholar
• AsefiVMojtahediZKhademiBNaeimiSGhaderiAHead and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control studyJ Laryngol Otol2009123444444818940019
   PubMed Web of Science ®Google Scholar
• PratesiCBortolinMTBidoliEInterleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal typeCancer Immunol Immunother2006551233016059673
   PubMed Web of Science ®Google Scholar
• FarhatKHassenEBouzgarrouNFunctional IL-18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patientsCytokine200843213213718555694
   PubMed Web of Science ®Google Scholar
• NongLGLuoBZhangLNongHBInterleukin-18 gene promoter polymorphism and the risk of nasopharyngeal carcinoma in a Chinese populationDNA Cell Biol2009281050751319622039
   PubMed Web of Science ®Google Scholar
• YangXQiuMTHuJWAssociation of interleukin-18 gene promoter -607 C>A and -137G>C polymorphisms with cancer risk: a meta-analysis of 26 studiesPLoS One201389e7367124066061
   PubMed Web of Science ®Google Scholar
• YuehTCWuCNHungYWThe Contribution of MMP-7 Genotypes to Colorectal Cancer Susceptibility in TaiwanCancer Genomics Proteomics201815320721229695403
   PubMed Web of Science ®Google Scholar
• ShenTCChangWSTsaiCWThe contribution of matrix metalloproteinase-1 promoter genotypes in Taiwan lung cancer riskAnticancer Res201838125325729277780
   PubMed Web of Science ®Google Scholar
• FolwacznyMGlasJTörökHPPolymorphisms of the interleukin-18 gene in periodontitis patientsJ Clin Periodontol200532553053415842270
   PubMed Web of Science ®Google Scholar
• ChanATTeoPMJohnsonPJNasopharyngeal carcinomaAnn Oncol20021371007101512176778
   PubMed Web of Science ®Google Scholar
• TsouYATsaiCWTsaiMHAssociation of caveolin-1 genotypes with nasopharyngeal carcinoma susceptibility in TaiwanAnticancer Res201131103629363221965789
   PubMed Web of Science ®Google Scholar
• TsaiCWTsaiMHShihLCAssociation of interleukin-10 (IL10) promoter genotypes with nasopharyngeal carcinoma risk in TaiwanAnticancer Res20133383391339623898109
   PubMed Web of Science ®Google Scholar
• LiuJCTsaiCWHsuCMContribution of double strand break repair gene XRCC3 genotypes to nasopharyngeal carcinoma risk in TaiwanChin J Physiol2015581647125687493
   PubMed Web of Science ®Google Scholar
• HuangCYTsaiCWHsuCMThe role of XRCC6/Ku70 in nasopharyngeal carcinomaInt J Oral Maxillofac Surg201544121480148526149939
   PubMed Web of Science ®Google Scholar
• TsaiCWChangWSGongCLContribution of matrix metallopeptidase-1 genotypes, smoking, alcohol drinking and areca chewing to nasopharyngeal carcinoma susceptibilityAnticancer Res20163673335334027354591
   PubMed Web of Science ®Google Scholar
• AggarwalBBShishodiaSSandurSKPandeyMKSethiGInflammation and cancer: how hot is the link?Biochem Pharmacol200672111605162116889756
   PubMed Web of Science ®Google Scholar
• LianHJinNLiXInduction of an effective anti-tumor immune response and tumor regression by combined administration of IL-18 and ApoptinCancer Immunol Immunother200756218119216767432
   PubMed Web of Science ®Google Scholar
• HerzykDJBugelskiPJHartTKWierPJPreclinical safety of recombinant human interleukin-18Toxicol Pathol200331555456114692624
   PubMed Web of Science ®Google Scholar
• GuoXGXiaYThe Interleukin-18 promoter -607C>A polymorphism contributes to nasopharyngeal carcinoma risk: evidence from a meta-analysis including 1,886 subjectsAsian Pac J Cancer Prev201314127577758124460336
   PubMedGoogle Scholar
• MakniHDaoudJBen SalahHHLA association with nasopharyngeal carcinoma in southern TunisiaMol Biol Rep20103752533253919714482
   PubMed Web of Science ®Google Scholar
• KaranikiotisCDaniilidisMKaryotisNHLA Class II alleles and the presence of circulating Epstein-Barr virus DNA in Greek patients with nasopharyngeal carcinomaStrahlenther Onkol2008184632533118535809
   PubMed Web of Science ®Google Scholar
• ZengXHXiaoLLLiJLuJXWangXNCorrelation of the polymorphism of HLA-A, B and DRB1 alleles with nasopharyngeal carcinoma in the south of ChinaXi Bao Yu Fen Zi Mian Yi Xue Za Zhi200723981982017825227
   PubMedGoogle Scholar
• HildesheimAAppleRJChenCJAssociation of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in TaiwanJ Natl Cancer Inst200294231780178912464650
   PubMedGoogle Scholar
• Mokni-BaizigNAyedKAyedFBAssociation between HLA-A/-B antigens and -DRB1 alleles and nasopharyngeal carcinoma in TunisiaOncology20016115558
   PubMed Web of Science ®Google Scholar
• WangRHuYYindomLMAssociation analysis between HLA-A, -B, -C, -DRB1, and -DQB1 with nasopharyngeal carcinoma among a Han population in Northwestern ChinaHum Immunol201475319720224389314
   PubMed Web of Science ®Google Scholar
• BurtRDVaughanTLMcknightBAssociations between human leukocyte antigen type and nasopharyngeal carcinoma in Caucasians in the United StatesCancer Epidemiol Biomarkers Prev19965118798878922295
   PubMed Web of Science ®Google Scholar
• YangHYuKZhangRThe HLA-DRB1 allele polymorphisms and nasopharyngeal carcinomaTumour Biol20163767119712827059731
   PubMedGoogle Scholar